In the pathophysiological context of MASLD, it has been consistently observed that elevated serum leptin levels coincide with reduced adiponectin concentrations, indicating that an increased leptin-to-adiponectin ratio (LAR) could potentially function as a biomarker for MASLD severity. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.